Condition

DS Stage I Plasma Cell Myeloma (2)

DS Stage II Plasma Cell Myeloma (2)

Breast Adenocarcinoma (1)

DS Stage III Plasma Cell Myeloma (1)

Metastatic Malignant Neoplasm to the Bone (1)

Musculoskeletal Complication (1)

Pain (1)

Urinary Complications (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

National Cancer Institute (NCI) (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

bortezomib (1)

laboratory biomarker analysis (1)

pegylated liposomal doxorubicin hydrochloride (1)

zoledronic acid (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

DS Stage II Plasma Cell Myeloma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma Trial in United States

Completed

DS Stage I Plasma Cell Myeloma
+2 more

Bortezomib
+2 more

Mountain View, California
+24 more

Sep 20, 2019

Breast Adenocarcinoma, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma Trial in Puerto Rico, United States

Completed

Has Results

Breast Adenocarcinoma
+6 more

zoledronic acid

Fairbanks, Alaska
+503 more

Oct 8, 2018